Tag: podcast
-
Advancing Muscular Dystrophy Research with Elizabeth McNally, MD, PhD
Elizabeth McNally, MD, PhD, talks about her recent discoveries advancing muscular dystrophy research.
-
Next-Generation COVID Vaccines with Pablo Penaloza-MacMaster, PhD
As the Delta variant of SARS-CoV-2 is causing breakthrough infections in some vaccinated people around the world, scientists at Northwestern Medicine are developing and studying potential next-generation COVID-19 vaccines that could be more effective at preventing and clearing breakthrough infections. Pablo Penaloza-MacMaster, PhD, an assistant professor of Microbiology-Immunology at Feinberg, discusses work in his lab…
-
The Evolution of Cardiac Monitoring with Rod Passman, MD
As heart conditions like arrhythmia become increasingly common, heart monitoring is becoming an even more important tool for disease prevention and treatment. Northwestern Medicine cardiac electrophysiologist Rod Passman, MD, who has over three decades of experience in the field, reviews the history of cardiac monitoring and looks to the future. He details his pioneering use…
-
Esophageal Diseases, Symptom Anxiety and Hypervigilance with John Pandolfino, MD
Esophageal diseases are extremely common, and symptoms such as trouble swallowing, chest pain, regurgitation and choking diminish quality of life. There can also be psychosocial effects for patients with these diseases, including hypervigilance — a heightened focus on physical symptoms — and symptom-specific anxiety such as fear of choking. Identifying patients with issues could help…
-
Northwestern Drug Kills Glioblastoma Tumor Cells with Priya Kumthekar, MD
An early clinical trial found that a spherical nucleic acid drug developed at Northwestern kills tumor cells in people with the fatal brain cancer glioblastoma. This is the first time a nanotherapeutic has been shown to cross the blood-brain barrier and cause cell death. Lead investigator Priya Kumthekar, MD, explains the results of the study.
-
Kidneys, COVID-19 and ACE2 Connection with Daniel Batlle, MD
Daniel Batlle, MD, professor of medicine in the Division of Nephrology and Hypertension at Northwestern, has been studying ACE2 and its potential therapeutic uses for many years. When the pandemic began, he proposed a hypothesis that soluble ACE2 could treat the SARS-CoV-2 virus and lead to survival and full recovery, and now he has some…
-
Neurological Complications of COVID-19 with Igor Koralnik, MD
COVID-19 can be a multi-system disease, impacting many organs and the entire nervous system. Igor Koralnik, MD, has been investigating the neurological complications of the disease and published the first study focused on long-term neurologic symptoms in COVID-19 “long haulers.” He explains the study and what he is seeing in the Neuro COVID-19 Clinic at…
-
Black Men and Prostate Cancer with Edward Schaeffer, MD, PhD
Black men are more likely to get prostate cancer and more than twice as likely to die from the disease than other men. Edward Schaeffer, MD, PhD, has developed a research team to better understand this problem. In this show he talks about his latest discoveries, which are paving the way to precision medicine for…
-
Pediatric Eczema and Scratch Sensors with Steve Xu, MD, MSc
Atopic dermatitis — or eczema — affects about 10 million children in the U.S., and the itching that accompanies this condition can cause pain and distress for kids who can’t always verbalize or quantify how much they’re suffering. But a new wearable sensor developed by Northwestern University scientists could help better monitor scratching and assess…
-
COVID-19 Vaccines and Pregnant Women with Emily Miller, MD, MPH
Recently, the director of the CDC officially recommended that pregnant women receive the vaccines for COVID-19. However, pregnant women are less likely than non-pregnant women to get vaccinated and are at greater risk of hospitalization and death from the disease. Emily Miller, MD, MPH, has been caring for pregnant patients at Prentice Women’s Hospital since…
